Thermo Fisher (TMO) Advances Health Equity via New Partnership
https://www.zacks.com/stock/news/2192709/thermo-fisher-tmo-advances-health-equity-via-new-partnership?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2192709
Dec 04, 2023 - Thermo Fisher (TMO) announces a collaboration with Project HOPE to improve health outcomes by enabling expanded access to HIV testing and support services in Nigeria.
0
BiomX (PHGE) Reports Positive Pulmonary Infection Treatment Data
https://www.zacks.com/stock/news/2192692/biomx-phge-reports-positive-pulmonary-infection-treatment-data?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2192692
Dec 04, 2023 - BiomX's (PHGE) BX004 showcases an impressive 14% conversion to a negative P. aeruginosa sputum culture at the end of treatment.
0
Neogen (NEOG) Unveils New Assay for Walnut Allergens Detection
https://www.zacks.com/stock/news/2192294/neogen-neog-unveils-new-assay-for-walnut-allergens-detection?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2192294
Dec 01, 2023 - Neogen's (NEOG) Veratox VIP for Walnut allergy test displays robust performance across sample types while keeping the Veratox product line's simple testing approach.
0
CVS Health's (CVS) Digital Focus Aids Growth, Macro Issues Ail
https://www.zacks.com/stock/news/2192251/cvs-health-s-cvs-digital-focus-aids-growth-macro-issues-ail?cid=CS-ZC-FT-analyst_blog|zer_report_update-2192251
Dec 01, 2023 - CVS Health's (CVS) Health Care Benefits segment demonstrates value to consumers and clients by successfully managing drug cost trends and bringing innovative clinical solutions to the market.
0